Athira Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 5.40 M | $2.41 M | 0.00% | 14.03% |
| VANGUARD GROUP INC | 11/13/2024 | 1.61 M | $719,426 | -1.31% | 4.19% |
| SIMPLIFY ASSET MANAGEMENT INC. | 11/12/2024 | 1.49 M | $665,785 | 0.00% | 3.88% |
| PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 1.49 M | $665,785 | 0.00% | 3.88% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 600,000 | $267,600 | -43.00% | 1.56% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 535,543 | $238,852 | 100.00% | 1.39% |
| PATHSTONE HOLDINGS, LLC | 11/07/2024 | 492,126 | $219,488 | -0.02% | 1.28% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 476,502 | $211,000 | 49.80% | 1.24% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 452,787 | $201,943 | 66.78% | 1.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 428,778 | $191,235 | 87.52% | 1.11% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 397,111 | $177,000 | 909.84% | 1.03% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 337,600 | $150,570 | -6.46% | 0.88% |
| BRISTLECONE ADVISORS, LLC | 10/24/2024 | 337,506 | $150,528 | 295.64% | 0.88% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 321,447 | $143,365 | -41.59% | 0.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 320,844 | $143,131 | 4.45% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 258,473 | $115,279 | -14.45% | 0.67% |
| LAIRD NORTON TRUST COMPANY, LLC | 11/14/2024 | 147,309 | $65,700 | 0.00% | 0.38% |
| STATE STREET CORP | 11/14/2024 | 107,781 | $48,070 | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 88,893 | $39,646 | -41.16% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 88,200 | $39,690 | 70.27% | 0.23% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 82,350 | $37,053 | 174.04% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2024 | 68,000 | $30,328 | 427.13% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 63,033 | $28,113 | 100.00% | 0.16% |
| CLARIUS GROUP, LLC | 10/09/2024 | 53,551 | $23,884 | 0.00% | 0.14% |
| INVST, LLC | 11/19/2024 | 45,000 | $20,070 | 66.67% | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 11/14/2024 | 40,227 | $17,941 | -0.62% | 0.10% |
| MORGAN STANLEY | 11/14/2024 | 34,012 | $15,169 | 46.60% | 0.09% |
| EASTERLY INVESTMENT PARTNERS LLC | 11/01/2024 | 33,500 | $14,941 | 0.00% | 0.09% |
| INTEGRITY FINANCIAL CORP /WA | 10/21/2024 | 32,786 | $14,623 | 0.00% | 0.09% |
| BRIGHTON JONES LLC | 10/22/2024 | 32,200 | $14,361 | 0.00% | 0.08% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 29,348 | $13,000 | 125.58% | 0.08% |
| JANE STREET GROUP, LLC | 11/15/2024 | 27,149 | $12,109 | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 23,600 | $10,526 | 9.26% | 0.06% |
| SIMON QUICK ADVISORS, LLC | 10/15/2024 | 20,538 | $9,160 | 0.00% | 0.05% |
| JOURNEY STRATEGIC WEALTH LLC | 11/12/2024 | 20,538 | $9,160 | 0.00% | 0.05% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 20,242 | $9,028 | 100.00% | 0.05% |
| BLAIR WILLIAM & CO/IL | 11/12/2024 | 20,000 | $8,920 | 100.00% | 0.05% |
| STONEX GROUP INC. | 11/12/2024 | 19,679 | $9,000 | 100.00% | 0.05% |
| SARGENT INVESTMENT GROUP, LLC | 11/06/2024 | 19,516 | $8,704 | 0.00% | 0.05% |
| MIRADOR CAPITAL PARTNERS LP | 10/04/2024 | 19,454 | $8,676 | -2.92% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 18,351 | $8,185 | -70.32% | 0.05% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 16,468 | $7,345 | 100.00% | 0.04% |
| LARSON FINANCIAL GROUP LLC | 11/12/2024 | 15,000 | $6,690 | 100.00% | 0.04% |
| ROTHSCHILD INVESTMENT LLC | 10/18/2024 | 12,900 | $5,753 | 0.00% | 0.03% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 12,468 | $6,000 | 0.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 11,828 | $5,276 | 1,169.10% | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 11,000 | $4,906 | -38.67% | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 10,118 | $4,513 | -4.07% | 0.03% |
| LINDBROOK CAPITAL, LLC | 11/01/2024 | 8,920 | $3,978 | -29.97% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2024 | 8,341 | $4,000 | -84.95% | 0.02% |
Athira Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 83 institutional investors and hedge funds held shares of Athira Pharma, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 5.4 M
VANGUARD GROUP INC: 1.61 M
Propel Bio Management, LLC: 1.49 M
Simplify Asset Management Inc.: 1.49 M
TANG CAPITAL MANAGEMENT LLC: 600,000
BlackRock Funding, Inc. /DE: 535,543
41.87% of Athira Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.58 M shares in the last 24 months. This purchase volume represents approximately $9.32 M in transactions.